Safety study of an investigational drug in healthy volunteers and people with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This early-phase study tests a new investigational drug called PATAS, first in healthy volunteers and then in people with type 2 diabetes, to see how safe it is and how the body handles it. It may help future treatments for diabetes, but it does not prove effectiveness yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can join as a healthy volunteer (ages 18–55) or as someone with type 2 diabetes (ages 18–65).
- For the diabetes part, you must have had type 2 diabetes for at least 6 months and manage it with only oral medicines (like metformin) or with diet and exercise.
- You must not use insulin or other injectable diabetes drugs for at least 90 days before starting.
- Your body mass index (BMI) must be between 20 and 35 (healthy group) or between 25 and 40 (diabetes group).
- You must be in good general health, with normal heart, liver, and kidney function tests.
- You must not have a history of severe allergic conditions, heart rhythm problems, or long QT syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.